Companies: 10,795·Total market cap: $144.5T
Microbot Medical Inc.

Microbot Medical Inc.

MBOTNASDAQHealthcare● Active
$1.82
$-0.02(-1.09%)
Market Cap$82938186
P/E Ratio
52W High$4.67
52W Low$1.6

Microbot Medical Inc.(MBOT)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

mbot · 股价预测 · 3 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 3 位华尔街分析师

SellBuy

Buy

3 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
合计: 3 · 买入占比: 66.7%

12 个月目标价

High

$4.00

Consensus

$4.00

+119.8% upside

Low

$4.00

Median: $4 · Last Close: $1.82

Microbot Medical Inc.(MBOT)的分析师共识为 Buy,基于过去 3 个月内 3 位华尔街分析师的评级。MBOT 的 12 个月平均目标价为 $4.00,相对当前价 $1.82 代表 +119.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$1.830.77%

1-day model range: $1.81–$1.85. Peak: $1.85 (+0.77%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-50.0%
2028$1-62.5%
2029$1-67.2%
2030$1-69.2%
2031-70.2%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)52.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · MBOT · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$1.92SELL
MA 10$1.91SELL
MA 20$1.90SELL
MA 50$2.12SELL
MA 100$2.18SELL
MA 200$2.44SELL
Current $MBOT · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.89SELL
EMA 10$1.90SELL
EMA 20$1.93SELL
EMA 50$2.07SELL
EMA 100$2.17SELL
EMA 200$2.23SELL
Current $MBOT · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-04-14
Maintains
BuyBuy
HC Wainwright & Co.2025-11-28
Maintains
BuyBuy
HC Wainwright & Co.2025-10-15
Maintains
BuyBuy
HC Wainwright & Co.2025-09-11
Maintains
BuyBuy
HC Wainwright & Co.2025-04-10
Maintains
BuyBuy
HC Wainwright & Co.2025-01-24
Maintains
BuyBuy
HC Wainwright & Co.2024-06-03
Maintains
BuyBuy
HC Wainwright & Co.2024-04-16
Maintains
BuyBuy
HC Wainwright & Co.2023-10-18
Maintains
BuyBuy
HC Wainwright & Co.2023-06-26
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Microbot Medical Inc. (MBOT) stock. Of the recent 24 rating actions, 0 were upgrades and 2 were downgrades. 3 analysts currently cover MBOT.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

MBOT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 98.9% YoY

Revenue Next Year

$5M

↑ 3929.4% YoY

EPS This Year

$-0.30

EPS Next Year

$-0.29

↓ 4.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MBOT EPS of $-0.30 for the current fiscal year, based on estimates from 3 analysts. The MBOT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MBOT 股价预测由两类独立数据源支撑:来自 3 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MBOT 的共识目标价为 $4.00(+119.8% 上行空间),分析师共识为 Buy。

MBOT 的短期预测(明日)为 $1.83(+0.77%)。 MBOT 对 2027 年的股价预测均值为 $1。 MBOT 对 2030 年的预测区间为 $1–$1。

Microbot Medical Inc. 在 NASDAQ 上市,代码 MBOT。MBOT 在 2027 年的整体展望偏积极,在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MBOT 预测 · 8 个问题

根据 3 位华尔街分析师,MBOT 的 12 个月平均目标价为 $4.00,最高 $4.00、最低 $4.00。若有图表,中位目标价可在上方查看。相对当前价 $1.82,隐含约 +119.8% 的上行空间。

MBOT 目标价MBOT 分析师目标价MBOT 12个月目标价目标价 MBOT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.